SearchDictionaryMobileLogin

Aortic Rupture

236  relevant articles (5 outcomes, 9 trials/studies) found for this Disease

Description: The tearing or bursting of the wall along any portion of the AORTA, such as thoracic or abdominal. It may result from the rupture of an aneurysm or it may be due to TRAUMA.

Also Known As:
Ruptured Aortic Aneurysm; Aneurysm, Ruptured Aortic; Aneurysms, Ruptured Aortic; Aortic Aneurysms, Ruptured; Aortic Ruptures; Rupture, Aortic; Ruptured Aortic Aneurysms; Ruptures, Aortic; Aortic Aneurysm, Ruptured

Relationship Network

Disease Context: Research Results

Related Diseases

1. Hemorrhage
2. Ischemia
3. Hypertension (High Blood Pressure)
4. Myocardial Infarction
5. Hypotension (Low Blood Pressure)

Experts

1. Neuhauser, B: 2 articles (07/2007 - 12/2004)
2. Waldenberger, P: 2 articles (07/2007 - 12/2004)
3. Jaschke, W: 2 articles (07/2007 - 12/2004)
4. Morishita, Kiyofumi: 2 articles (04/2007 - 11/2004)
5. Kawaharada, Nobuyoshi: 2 articles (04/2007 - 11/2004)
6. Abe, Tomio: 2 articles (04/2007 - 11/2004)
7. Kurimoto, Yoshihiko: 2 articles (04/2007 - 11/2004)
8. Jiang, F: 1 article (11/2007)
9. Dusting, G J: 1 article (11/2007)
10. Jones, G T: 1 article (11/2007)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Aortic Rupture:
1. glucuronyl glucosamine glycan sulfate (Vessel)IBA
2. Vitamin EFDA Link
3. Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
4. Antihypertensive Agents (Antihypertensives)IBA
5. Polyethylene Terephthalates (Polyethylene Terephthalate)IBA
6. Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
7. AmylasesIBA
8. Direction compoundIBA
9. Diethylstilbestrol (Stilbestrol)FDA Link
10. AminopropionitrileIBA

Therapies and Procedures

1. Thoracotomy
2. Angioplasty (Angioplasties)
3. Chest Tubes (Chest Tube)
09/01/1997 - "In 42 patients (41%) the additional TCT findings resulted in a change of therapy: chest tube placement, chest tube correction of pneumothoraces or large hemothoraces (n = 31), change in mode of ventilation and respiratory care (n = 14), influence on the management of fracture stabilization (n = 12), laparotomy in cases of diaphragmatic lacerations (n = 2), bronchoscopy for atelectasis (n = 2), exclusion of aortic rupture (n = 2), endotracheal intubation (n = 1), and pericardiocentesis (n = 1)"
06/01/1997 - "In 42 patients (41%) the additional TCT findings did affect, the therapy selected: chest tube placement or chest tube correction in mostly anteriorly located pneumothoraces or large hemothoraces (n = 31), influence on ventilation mode and respiratory care (n = 14), influence on the management of fracture stabilization (n = 12), laparotomy in cases of diaphragmatic lacerations (n = 2), bronchoscopy for atelectasis (n = 2), exclusion of aortic rupture (n = 2), endotracheal intubation (n = 1), pericardiocentesis (n = 1)"
01/01/1997 - "In 42 patients (41%) the additional TCT findings resulted in a change of therapy: chest tube placement or chest tube correction of pneumothoraces or large hemothoraces (n = 31), change in mode of ventilation and respiratory care (n = 14), influence on the management of fracture stabilization (n = 12), laparotomy in cases of diaphragmatic lacerations (n = 2), bronchoscopy for atelectasis (n = 2), exclusion of aortic rupture (n = 2), endotracheal intubation (n = 1), pericardiocentesis (n = 1)"
08/01/1987 - "The following occurred with significantly greater frequency in patients with thoracic aortic rupture than in those without: history of significant hypotension (mean arterial pressure less than 80 mm Hg) (p less than 0.04); the presence of upper extremity hypertension, bilateral lower extremity pulse pulse deficits, or an initial chest tube output greater than 750 ml of blood (p less than 0.05); and greater incidence of myocardial contusions, intra-abdominal injuries, and pelvic fractures compared with patients without thoracic aortic rupture (p less than 0.05)"
Order ALL the reference details at left...
4. Transplants (Transplant)
5. Stents

Best Treatments:
Research Summary Report
on Aortic Rupture
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 5 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>